MEDIGEN BIOTECHNOLOGY CORPORATIONMEDIGEN BIOTECHNOLOGY CORPORATIONMEDIGEN BIOTECHNOLOGY CORPORATION

MEDIGEN BIOTECHNOLOGY CORPORATION

No trades
See on Supercharts

3176 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Medigen Biotechnology Corp. engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine products, and the production and sale of vaccine-related products. It operates through the following segments: Nucleic Acid Testing, New Drug and Vaccine Research and Development, Cytotheraphy, Generic Drug, Aesthetic, Medicine Product, and Dietary Supplement. The company was founded on December 31, 1999 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
3176 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company